Načítá se...
Update on the role of pembrolizumab in patients with unresectable or metastatic colorectal cancer
Colorectal cancer (CRC) is the third most common cancer type in both men and women in the USA. Most patients with CRC are diagnosed as local or regional disease. However, the survival rate for those diagnosed with metastatic disease remains disappointing, despite multiple treatment options. Cancer t...
Uloženo v:
| Vydáno v: | Therap Adv Gastroenterol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8246487/ https://ncbi.nlm.nih.gov/pubmed/34262612 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17562848211024460 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|